Acinetobacter baumani and Pseudomonas aeruginosa drug susceptibility after bacteriological analysis of sputum in patients mechanically ventilated in ICU

G. Meletis, E. Astrinaki, M. Ferdoutsis, E. Vakouti, K. Hahlioutis, K. Antoniou, N. Zografistos, G. Vrouhos, N. Bachlitzanakis (Heraklion, Greece)

Source: Annual Congress 2003 - Severe pulmonary infection and sepsis
Session: Severe pulmonary infection and sepsis
Session type: Thematic Poster Session
Number: 2859
Disease area: Respiratory critical care, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Meletis, E. Astrinaki, M. Ferdoutsis, E. Vakouti, K. Hahlioutis, K. Antoniou, N. Zografistos, G. Vrouhos, N. Bachlitzanakis (Heraklion, Greece). Acinetobacter baumani and Pseudomonas aeruginosa drug susceptibility after bacteriological analysis of sputum in patients mechanically ventilated in ICU. Eur Respir J 2003; 22: Suppl. 45, 2859

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Carbapenems for the treatment of immunocompetent adult patients with nosocomial pneumonia
Source: Eur Respir J 2007; 29: 548-560
Year: 2007



Antibiotic sensitivity of pseudomonas aeroginosa isolates of respiratory secretions taken from ICU patients of the NRITLD
Source: Eur Respir J 2004; 24: Suppl. 48, 641s
Year: 2004

Acinetobacter baumanii as a severity marker in a respiratory ICU
Source: Eur Respir J 2006; 28: Suppl. 50, 786s
Year: 2006

Comparative results of preemptive therapies in mechanically ventilated patients with carbapanem-resistant Acinetobacter baumannii (CRAB)
Source: International Congress 2017 – Hospital-acquired infections: from prevention to treatment
Year: 2017




Clinical and microbiological characteristics of Pseudomonas aeruginosa isolates from patients with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 58s
Year: 2005

Acinetobacter baumanii and Stenotrophomonas maltophilia are associated with lower airway infections in tracheostomised children and young adults.
Source: International Congress 2017 – New insights into paediatric respiratory infections
Year: 2017

The resistance rates of Acinetobacter baumannii at endotracheal aspirate cultures
Source: Annual Congress 2012 - Respiratory infections: a clinical point of view
Year: 2012

Association of acinetobacter baumannii respiratory isolates with hospital outcomes in ventilated patients
Source: Eur Respir J 2006; 28: Suppl. 50, 785s
Year: 2006

Clinical outcomes of tigecycline in the treatment of critically ill patients with multidrug-resistant Acinetobactor baumannii infection
Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections
Year: 2011

Potential treatment for nosocomial respiratory strains of extreme drug resistant acinetobacter baumanii
Source: Eur Respir J 2007; 30: Suppl. 51, 410s
Year: 2007

The clinical evaluation of patients with Pseudomonas aeruginosa detected in respiratory specimens
Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens
Year: 2012

Acinetobacter baumannii infection and colonization among pediatric patients in pediatric ICU and other ICUs
Source: International Congress 2018 – Neonatology and paediatric intensive care
Year: 2018

Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors
Source: Eur Respir J 2010; 35: 598-615
Year: 2010



Aetiopathogenesis of VAP revisited
Source: Eur Respir Mon 2011; 53: 1-10
Year: 2011


Clinical  profile  and outcome of patients with sputum positive Acinetobacter baumanni infection
Source: International Congress 2018 – Difficult-to-treat respiratory infections
Year: 2018

Prognosis of Acinetobacter baumannii bacteraemia in a respiratory ICU: 10 years‘ experience
Source: Eur Respir J 2005; 26: Suppl. 49, 222s
Year: 2005

Novel Pseudomonas aeruginosa scoring system to guide empiric anti-pseudomonal therapy in COPD patients with community-acquired pneumònia
Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections
Year: 2020


Resistant and panresistant A. baumanni infection in ICU
Source: Annual Congress 2010 - Intensive care unit outcome
Year: 2010


Study on the molecular epidemiology of stenotrophomonas maltophilia infection in patients on mechanical ventilation
Source: Eur Respir J 2006; 28: Suppl. 50, 785s
Year: 2006

Pseudomonas aeruginosa and legionella pneumophilia in water of dental units
Source: Eur Respir J 2006; 28: Suppl. 50, 486s
Year: 2006